Lucid Genomics is an AI-powered platform that focuses on diagnostics and biomarker detection.
Lucid Genomics has raised $1.4M in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2024.
Lucid Genomics's investors include another.vc, Caesar Ventures, Max Planck Foundation, BIF Partners, MAX!mize.
Lucid Genomics is headquartered in Berlin, Germany.
Lucid Genomics is an AI-powered platform that focuses on diagnostics and biomarker detection.
Lucid Genomics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lucid Genomics — Funding & Investors." VCBacked, September 2, 2024, https://www.vcbacked.co/company/lucid-genomics. Accessed October 28, 2026.
VCBacked. (2024). Lucid Genomics — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/lucid-genomics
{{cite web |title=Lucid Genomics — Funding & Investors |url=https://www.vcbacked.co/company/lucid-genomics |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated